Compare ESPR & GCMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ESPR | GCMG |
|---|---|---|
| Founded | 2008 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 793.7M | 731.1M |
| IPO Year | 2013 | N/A |
| Metric | ESPR | GCMG |
|---|---|---|
| Price | $3.29 | $11.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $7.20 | ★ $15.67 |
| AVG Volume (30 Days) | ★ 2.9M | 678.5K |
| Earning Date | 04-02-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.14% |
| EPS Growth | ★ 86.21 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $332,314,000.00 | N/A |
| Revenue This Year | $27.35 | $7.28 |
| Revenue Next Year | N/A | $11.70 |
| P/E Ratio | ★ N/A | $28.21 |
| Revenue Growth | ★ 185.66 | N/A |
| 52 Week Low | $0.73 | $9.86 |
| 52 Week High | $4.18 | $13.71 |
| Indicator | ESPR | GCMG |
|---|---|---|
| Relative Strength Index (RSI) | 43.62 | 53.87 |
| Support Level | $3.16 | $11.36 |
| Resistance Level | $3.41 | $11.98 |
| Average True Range (ATR) | 0.14 | 0.56 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 5.75 | 59.72 |
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG and absolute return strategies. Company invest maximum in Private Equity. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.